Skip to content
Mable logo

Mable

Mable is a YC Summer 2021 (S21) company. Based in San Francisco, CA, USA; Remote. Team of 7.

  • Health Tech
  • Telehealth
  • Genomics

About Mable

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

Mable runs a personalized migraine clinic that uses genetic and biomarker data to match patients with the right medication, then pairs that with ongoing telehealth care. The service replaces the trial-and-error process that migraine sufferers typically endure with neurologists or primary care physicians before finding an effective treatment. Patients get a DNA-informed medication plan and continuous specialist oversight, without in-person clinic visits.

Go-to-market

Migraine sufferers sign up directly through Mable's telehealth platform, making it a self-serve consumer health service that bypasses traditional in-person neurology referrals.

From the Y Combinator listing

How Mable describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

First personalized migraine clinic using genetics and telehealth.

Mable is a personalized migraine clinic using DNA to find and provide the right medication alongside continuous expert care Using our approach, patients have an 80% higher treatment satisfaction rate, have one extra day per week to enjoy their life and get 55% pain reduction.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
San Francisco, CA, USA; Remote
Team size
7
Status
Acquired
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works